HEALWELL AI Revenue Hits $103.8M After 427% Growth

Edgen Stock

·Mar 19 2026, 11:41

Share to

Share to

Copy link

Key Takeaways

HEALWELL AI posted record revenue and achieved positive adjusted EBITDA for the first time in fiscal 2025, signaling its AI platform strategy is gaining traction. However, its net loss also increased, reflecting significant restructuring costs as it transitioned into a pure-play AI firm. The company is now focused on global scaling and improving profitability in 2026.

Record Revenue: Fiscal 2025 revenue from continuing operations increased 427% to $103.8 million, up from $19.7 million in the prior year.
Profitability Milestone: The company achieved its first full year of positive Adjusted EBITDA, reporting $2.3 million compared to a $14.2 million loss in fiscal 2024.
Strategic Pivot: HEALWELL divested non-core assets to become a pure-play AI and software company, ending the year with $18.6 million in cash.

Revenue Jumps 427% as AI Strategy Delivers

On March 19, 2026, HEALWELL AI announced record results for fiscal 2025, driven by its strategic shift to an AI-centric platform model. Annual revenue from continuing operations reached approximately $103.8 million, a 427% increase from the $19.7 million recorded in fiscal 2024. This growth was significantly influenced by the acquisition of Orion Health and organic expansion. The company also achieved a critical profitability milestone, reporting its first full year of positive Adjusted EBITDA of $2.3 million, a sharp turnaround from the $14.2 million Adjusted EBITDA loss in the previous year.

Net Loss Widens to $39.1M During Strategic Overhaul

Despite the strong top-line performance, HEALWELL's IFRS net loss from continuing operations widened to $39.1 million from $24 million in fiscal 2024. This increase reflects a period of intense restructuring as the company transitioned into a pure-play AI and software business. During the fourth quarter of 2025, HEALWELL completed several strategic divestments, including clinical assets, which generated approximately $9.7 million in cash. The company ended the fiscal year with an improved balance sheet, holding $18.6 million in cash.

Management Targets 10% Adjusted EBITDA Margin in 2026

Looking ahead, management is focused on scaling its AI platform and capitalizing on its enterprise customer base across 11 countries. HEALWELL is targeting an exit run-rate Adjusted EBITDA margin of approximately 10% in 2026 as synergies from the Orion Health integration are fully realized. The company's parent, WELL Health Technologies, which consolidates HEALWELL's results, views the AI firm as a key part of its strategy. This backing, combined with a focus on global contracts and deepening AI adoption, underpins the company's path toward sustained profitability.